BG103002A - Използване на плевромутилинови производни във ветеринарната практика - Google Patents

Използване на плевромутилинови производни във ветеринарната практика

Info

Publication number
BG103002A
BG103002A BG103002A BG10300298A BG103002A BG 103002 A BG103002 A BG 103002A BG 103002 A BG103002 A BG 103002A BG 10300298 A BG10300298 A BG 10300298A BG 103002 A BG103002 A BG 103002A
Authority
BG
Bulgaria
Prior art keywords
pigs
infection
caused
serpullina
mycoplasma
Prior art date
Application number
BG103002A
Other languages
English (en)
Other versions
BG64369B1 (bg
Inventor
David Burch
Paul Ripley
Erich Zeisl
Original Assignee
Biochemie Gesellschaft M.B.H.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9614019.9A external-priority patent/GB9614019D0/en
Priority claimed from GBGB9614016.5A external-priority patent/GB9614016D0/en
Priority claimed from GBGB9614014.0A external-priority patent/GB9614014D0/en
Priority claimed from GBGB9614013.2A external-priority patent/GB9614013D0/en
Priority claimed from GBGB9614012.4A external-priority patent/GB9614012D0/en
Priority claimed from GBGB9614015.7A external-priority patent/GB9614015D0/en
Priority claimed from GBGB9614018.1A external-priority patent/GB9614018D0/en
Application filed by Biochemie Gesellschaft M.B.H. filed Critical Biochemie Gesellschaft M.B.H.
Publication of BG103002A publication Critical patent/BG103002A/bg
Publication of BG64369B1 publication Critical patent/BG64369B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Feed For Specific Animals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Изобретението се отнася до съединение с формула@@под формата на свободна база или като приемлива заветеринарната медицина сол за терапия на животни с ветеринарни заболявания като вторични инфекции вследствие повишаване броя на животните на единица площ. Инфекцията е причинена от бактерии, избрани от групата Serpulina pilosicoli, Lawsonia intracellularis, Pasteurella multocida, Pasteurella haemolytica. Изобретението се отнася също до смеси на посочените съединения.
BG103002A 1996-07-04 1998-12-08 Използване на плевромутилинови производни във ветеринарната практика BG64369B1 (bg)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GBGB9614019.9A GB9614019D0 (en) 1996-07-04 1996-07-04 Organic compounds
GBGB9614016.5A GB9614016D0 (en) 1996-07-04 1996-07-04 Organic compounds
GBGB9614014.0A GB9614014D0 (en) 1996-07-04 1996-07-04 Organic compounds
GBGB9614017.3A GB9614017D0 (en) 1996-07-04 1996-07-04 Organic compounds
GBGB9614013.2A GB9614013D0 (en) 1996-07-04 1996-07-04 Organic compounds
GBGB9614012.4A GB9614012D0 (en) 1996-07-04 1996-07-04 Organic compounds
GBGB9614015.7A GB9614015D0 (en) 1996-07-04 1996-07-04 Organic compounds
GBGB9614018.1A GB9614018D0 (en) 1996-07-04 1996-07-04 Organic compounds

Publications (2)

Publication Number Publication Date
BG103002A true BG103002A (bg) 1999-09-30
BG64369B1 BG64369B1 (bg) 2004-12-30

Family

ID=27571326

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103002A BG64369B1 (bg) 1996-07-04 1998-12-08 Използване на плевромутилинови производни във ветеринарната практика

Country Status (25)

Country Link
US (1) US6130250A (bg)
EP (4) EP1813272B1 (bg)
JP (1) JP4165769B2 (bg)
CN (1) CN1121216C (bg)
AT (2) ATE509625T1 (bg)
AU (1) AU718701B2 (bg)
BG (1) BG64369B1 (bg)
BR (1) BR9710208A (bg)
CA (1) CA2256514C (bg)
CZ (4) CZ298444B6 (bg)
DE (1) DE69740162D1 (bg)
DK (2) DK1813272T3 (bg)
ES (2) ES2360813T3 (bg)
GB (1) GB9614017D0 (bg)
HU (1) HU230325B1 (bg)
IL (1) IL127299A (bg)
NO (1) NO326117B1 (bg)
NZ (1) NZ333261A (bg)
OA (1) OA10951A (bg)
PL (1) PL189204B1 (bg)
PT (2) PT1813272E (bg)
RU (1) RU2197237C2 (bg)
SK (4) SK285711B6 (bg)
UA (1) UA56173C2 (bg)
WO (1) WO1998001127A1 (bg)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI260220B (en) * 1999-11-22 2006-08-21 Novartis Ag A pharmaceutical composition for the transdermal treatment of bacterial infections in animals
TWI228048B (en) 1999-12-09 2005-02-21 Novartis Ag New formulation
GB0017031D0 (en) * 2000-07-11 2000-08-30 Biochemie Gmbh Antimicrobials
US6682762B2 (en) * 2001-10-09 2004-01-27 Heart-O-Dixie Animal Nutrition, Llc Poultry and livestock feed additive
CO5390081A1 (es) 2001-11-28 2004-04-30 Novartis Ag Compuestos organicos
EP1686115A1 (de) * 2005-01-26 2006-08-02 Novartis AG Organische Säureadditionssalze von Valnemulin
DE102006021493B4 (de) * 2006-05-09 2010-04-01 Bruker Daltonik Gmbh Massenspektrometrische Messung mikrobieller Resistenzen
EP2014645A1 (en) * 2007-07-13 2009-01-14 Nabriva Therapeutics AG Pleuromutilin derivatives and their use as antimicrobials
CN101690717B (zh) * 2009-09-30 2013-03-06 北京大北农动物保健科技有限责任公司 一种兽用沃尼妙林及其盐的预混剂及制备方法
CN102415989A (zh) * 2011-09-30 2012-04-18 上海恒丰强动物药业有限公司 盐酸沃尼妙林溶液剂及其制备方法
CN103520099A (zh) * 2013-10-30 2014-01-22 王玉万 含有效成份为沃尼妙林的长效注射剂

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4130709A (en) * 1977-12-08 1978-12-19 Eli Lilly And Company Pleuromutilin glycoside derivatives
US4247542A (en) * 1978-06-22 1981-01-27 Eli Lilly And Company A-40104 Antibiotics and process for production thereof
EP0153277B1 (de) * 1984-02-17 1987-08-26 Sandoz Ag Neue Pleuromutilinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung
DE3405632A1 (de) * 1984-02-17 1985-08-22 Sandoz-Patent-GmbH, 7850 Lörrach Neue pleuromutilinderivate, verfahren zu ihrer herstellung und ihre verwendung
AT392272B (de) * 1989-10-03 1991-02-25 Biochemie Gmbh Verfahren zur herstellung eines pleuromutilinderivats und seiner saeureadditionssalze
HU208115B (en) * 1989-10-03 1993-08-30 Biochemie Gmbh New process for producting pleuromutilin derivatives
AT400674B (de) * 1991-07-24 1996-02-26 Biochemie Gmbh Pharmazeutische pleuromutilin-zubereitung
CN1039585C (zh) * 1993-01-01 1998-08-26 生化企业 截短侧耳素衍生物与环糊精的配合物和含有它的药物制剂

Also Published As

Publication number Publication date
HU230325B1 (hu) 2016-02-29
CA2256514C (en) 2006-11-28
DK0910363T3 (da) 2011-09-05
SK286431B6 (sk) 2008-10-07
PL330726A1 (en) 1999-05-24
IL127299A0 (en) 1999-09-22
OA10951A (en) 2003-02-26
CZ298446B6 (cs) 2007-10-03
NO986198D0 (no) 1998-12-30
US6130250A (en) 2000-10-10
IL127299A (en) 2005-05-17
CN1121216C (zh) 2003-09-17
CZ298444B6 (cs) 2007-10-03
HUP9903103A2 (hu) 2000-02-28
PL189204B1 (pl) 2005-07-29
SK286445B6 (sk) 2008-10-07
EP0910363B1 (en) 2011-05-18
BR9710208A (pt) 1999-08-10
EP1810672A1 (en) 2007-07-25
JP4165769B2 (ja) 2008-10-15
HUP9903103A3 (en) 2000-04-28
CZ298445B6 (cs) 2007-10-03
EP1813272B1 (en) 2011-03-30
AU718701B2 (en) 2000-04-20
PT910363E (pt) 2011-05-31
SK285857B6 (sk) 2007-09-06
SK285711B6 (sk) 2007-06-07
GB9614017D0 (en) 1996-09-04
AU3692997A (en) 1998-02-02
BG64369B1 (bg) 2004-12-30
NZ333261A (en) 2000-09-29
JP2000514072A (ja) 2000-10-24
CA2256514A1 (en) 1998-01-15
ES2364414T3 (es) 2011-09-01
UA56173C2 (uk) 2003-05-15
RU2197237C2 (ru) 2003-01-27
ATE503475T1 (de) 2011-04-15
SK2799A3 (en) 1999-09-10
NO986198L (no) 1998-12-30
PT1813272E (pt) 2011-04-29
EP1813272A1 (en) 2007-08-01
CZ298385B6 (cs) 2007-09-19
ES2360813T3 (es) 2011-06-09
DE69740162D1 (de) 2011-05-12
CN1223576A (zh) 1999-07-21
DK1813272T3 (da) 2011-07-18
CZ438198A3 (cs) 1999-03-17
ATE509625T1 (de) 2011-06-15
WO1998001127A1 (en) 1998-01-15
NO326117B1 (no) 2008-09-29
EP1808171A1 (en) 2007-07-18
EP0910363A1 (en) 1999-04-28

Similar Documents

Publication Publication Date Title
BG103002A (bg) Използване на плевромутилинови производни във ветеринарната практика
EP0597852A4 (en) PORCINE PNEUMONIA VACCINE AND PROCESS FOR PREPARING THE SAME.
YU43425B (en) Process for obtaining 4"-epi-9-deoxo-9a-methyl-9a-aza-9a-homoerytromycine a
PT88448A (pt) Process for preparing antiprotozoal pharmaceutical compositionscontaining azithromycin or a derivative thereof
ES8605375A1 (es) Un procedimiento para preparar dicha composicion veterinaria a base de bacterias anaerobias y un agente conservador de la eficacia de dichas bacterias.
IE782421L (en) Pleuromutilin glycosides
NZ226208A (en) Vaccine for mycoplasma infections in poultry
IE902378L (en) Bacterial preparation for use in poultry
RU99102247A (ru) Применение в ветеринарии производного плевромутилина
NZ217679A (en) Antibiotic fermentates from kibdelosporangium aridum largum and compositions
AU583586B2 (en) Compositions for feeding animals
IL59447A0 (en) Antibiotic a-33512 factor b aglycone and the pharmaceutically-acceptable acid-addition salts thereof,process of producing them,a feed composition suitable for the nutrition of ruminant animals and poultry and a method of increasing feed-utilization efficiency of ruminant animals and poultry
SE8501532D0 (sv) Nya lekemedelskombinationer med synergistisk verkan och forfarande for deras framstellning
EP0234348A3 (en) N-glycosyl amide derivatives, method for their preparation and their use as medicaments
GR78600B (bg)
AU1102388A (en) Swine dysentery vaccine
Stipkovits Recent situation and prospects in control of respiratory and enteral diseases of swine
EP0257615A3 (en) Macrolide antibiotic, microbiologic method for its preparation and its use as a medicament
RO81008B1 (ro) Imunostimulator de natura bacteriana pentru bovine si procedeu de preparare a acestuia
ZA906550B (en) Methods and compositions for controlling protozoal infection in poultry,swine and ruminant animals
EP0316163A3 (en) Tetronasin or derivatives thereof for veterinary treatment
RU96114609A (ru) Способ кормления молодняка свиней